Covered recipient · General Payments record
FERNANDO BUESO
General Payments · PY2018–2024
$3,312.21
- Reported across 167 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $381.09 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exact Sciences Corporation | $85.93 | 4 |
| MERZ NORTH AMERICA, INC. | $57.54 | 1 |
| Lilly USA, LLC | $54.47 | 2 |
| PFIZER INC. | $45.42 | 2 |
| Novo Nordisk AS | $36.57 | 2 |
| Amgen Inc. | $28.57 | 2 |
| ABBVIE INC. | $28.43 | 1 |
| Astellas Pharma US Inc | $26.90 | 1 |
| Currax Pharmaceuticals LLC | $17.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.43 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103387381 | CMS |
| Amgen Inc. | $14.86 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111538783 | CMS |
| Amgen Inc. | $13.71 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111538785 | CMS |
| Astellas Pharma US Inc | $26.90 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139342514 | CMS |
| Currax Pharmaceuticals LLC | $17.26 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089510812 | CMS |
| Exact Sciences Corporation | $20.98 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128383888 | CMS |
| Exact Sciences Corporation | $19.36 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128383892 | CMS |
| Exact Sciences Corporation | $24.84 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128383896 | CMS |
| Exact Sciences Corporation | $20.75 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128383900 | CMS |
| Lilly USA, LLC | $19.71 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134976228 | CMS |
| Lilly USA, LLC | $34.76 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134967151 | CMS |
| MERZ NORTH AMERICA, INC. | $57.54 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146369781 | CMS |
| Novo Nordisk Inc | $20.34 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108575390 | CMS |
| Novo Nordisk Inc | $16.23 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108574150 | CMS |
| PFIZER INC. | $17.91 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131696247 | CMS |
| PFIZER INC. | $27.51 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132036296 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.